https://www.globenewswire.com/fr/news-release/2025/10/07/3162367/0/en/Coave-Therapeutics-demonstrates-superiority-of-its-novel-suprachoroidal-capsid-at-ESGCT-Congress-2025.html
Coave Therapeutics demonstrates superiority of its novel
Lead suprachoroidal capsid coAAV-SCS-01 demonstrated up to 26x outperformance of other capsids in targeting RPE-choroid and retinal cellscoAAV-SCS-01...
therapeuticsdemonstratessuperioritynovel